Sialorrhoea and Drooling in Patients with Parkinson’s Disease

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Drugs & Aging

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/0002512-200825120-00003PMID 19021300
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.

  2009cited by this paper
• Deep Brain Stimulation of the Subthalamic Nucleus for the Treatment of Parkinson's Disease

  2008cited by this paper
• Ipratropium bromide spray as treatment for sialorrhea in Parkinson's disease

  2007cited by this paper
• Management of drooling: 10 years after the Consortium on Drooling, 1990.

  2007cited by this paper
• Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease

  2007cited by this paper
• Treatment of sialorrhoea in patients with Parkinson's disease: best current evidence

  2007cited by this paper
• Clozapine-Induced Hypersalivation: A Review of Treatment Strategies

  2007cited by this paper
• Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing

  2007cited by this paper
• Sialorrhea in Parkinson's disease: A review

  2007cited by this paper
• Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism

  2007cited by this paper
• Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson's disease

  2007cited by this paper
• Impact of drooling in Parkinson’s disease

  2007cited by this paper
• Quantitative study of salivary secretion in Parkinson's disease

  2006cited by this paper
• Deep brain stimulation for the treatment of Parkinson's disease.

  2006cited by this paper
• Hypersalivation induced by olanzapine with fluvoxamine.

  2006cited by this paper
• Drooling

  2006cited by this paper
• Saliva control issues in the neurologically challenged. A 30 year experience in team management.

  2006cited by this paper
• Detection of motor and non-motor symptoms of end-of dose wearing-off in Parkinson's disease using a dedicated questionnaire: a Belgian multicenter survey.

  2006cited by this paper
• Botulinum toxin type A for drooling in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study

  2006cited by this paper
• The DONPAD-study--treatment of dementia in patients with Parkinson's disease with donepezil.

  2006cited by this paper
• Drooling of saliva: a review of the etiology and management options.

  2006cited by this paper
• Relationships between age, drugs, oral sensorial complaints and salivary profile.

  2005cited by this paper
• Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial

  2005cited by this paper
• Salivary production in Parkinson's disease

  2005cited by this paper
• Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations

  2005cited by this paper
• Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUT

  2004cited by this paper
• Guanfacine treatment of clozapine-induced sialorrhea.

  2004cited by this paper
• Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease.

  2004cited by this paper
• The effects of dopamine receptor agonists and antagonists on the secretory rate of cockroach (Periplaneta americana) salivary glands.

  2004cited by this paper
• Assessment of Salivary Flow Rate: Biologic Variation and Measure Error

  2004cited by this paper
• A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease

  2004cited by this paper
• Etiologic Diagnosis of Sensorineural Hearing Loss in Adults

  2004cited by this paper
• An apparent radiation-induced carcinoma of the parotid gland following treatment for adenoid cystic carcinoma of the sublingual gland: a case report.

  2004cited by this paper
• Autonomic nervous system dysfunction in Parkinson’s disease

  2003cited by this paper
• Amantadine in Parkinson's disease.

  2003cited by this paper
• [Sialorrhea in patients with Parkinson. A six year prospective study].

  2003cited by this paper
• Double‐blind, placebo‐controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism

  2003cited by this paper
• Area postrema mediates gastric motor response induced by apomorphine in rats.

  2003cited by this paper
• A randomized trial of botulinum toxin A for treatment of drooling

  2003cited by this paper
• A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling

  2003cited by this paper
• Sublingual Atropine for sialorrhea secondary to parkinsonism: A pilot study

  2002cited by this paper
• Systematic evaluation of rating scales for impairment and disability in Parkinson's disease

  2002cited by this paper
• An essay on the shaking palsy. 1817.

  2002cited by this paper
• Basal Ganglia and Functions of the Autonomic Nervous System

  2002cited by this paper
• Treatment interventions for Parkinson's disease: an evidence based assessment.

  2002cited by this paper
• Results of radiotherapy for drooling in amyotrophic lateral sclerosis.

  2002cited by this paper
• Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson's disease

  2002cited by this paper
• A review of saliva: normal composition, flow, and function.

  2001cited by this paper
• Study of quantitative oral radioactivity in salivary gland scintigraphy and determination of the clinical stage of Sjögren's syndrome.

  2001cited by this paper
• Development of a Visual Analogue Scale questionnaire for subjective assessment of salivary dysfunction.

  2001cited by this paper
• Drooling in Parkinson's disease: a novel speech and language therapy intervention.

  2001cited by this paper
• External radiation of the parotid glands significantly reduces drooling in patients with motor neurone disease with bulbar paresis.

  2001cited by this paper
• Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ.

  2001cited by this paper
• Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin.

  2001cited by this paper
• The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system

  2001cited by this paper
• Bilateral pallidotomy for treatment of Parkinson's disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation

  2001cited by this paper
• Determination of Variation of Stimulated Salivary Flow Rates

  2000cited by this paper
• Comparison of three salivary flow rate assessment methods in an elderly population.

  2000cited by this paper
• Gastrointestinal Motility Problems in Patients with Parkinson’s Disease

  1999cited by this paper
• Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson's disease: neuropsychological and neurological side effects. Report of four cases and review of the literature.

  1999cited by this paper
• A study of salivary secretion in Parkinson's disease.

  1999cited by this paper
• Essentials of head and neck oncology

  1998cited by this paper
• The role of radiation therapy in the management of sialorrhea.

  1998cited by this paper
• Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: dose-response relationships.

  1998cited by this paper
• Gastrointestinal Motility Problems in Patients with Parkinson’s Disease

  1997cited by this paper
• Trihexyphenidyl treatment of clozapine‐induced hypersalivation

  1997cited by this paper
• A systematic approach to the patient with dysphagia.

  1997cited by this paper
• Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment--botulinum toxin A injections of the parotid glands.

  1997cited by this paper
• Glycopyrrolate treatment of chronic drooling.

  1996cited by this paper
• EFFECT OF ANTIREFLUX MEDICATION ON SALIVARY DROOLING IN CHILDREN WITH CEREBRAL PALSY

  1996cited by this paper
• Aging and saliva: a review of the literature.

  1996cited by this paper
• The control of oral secretions in bulbar ALS/MND.

  1996cited by this paper
• Prepharyngeal dysphagia in Parkinson's disease

  1996cited by this paper
• Diversion of salivary flow to treat drooling in patients with cerebral palsy.

  1996cited by this paper
• Mechanisms of oral-pharyngeal dysphagia in patients with Parkinson's disease.

  1996cited by this paper
• A modified device for long term sampling of parotid saliva in various experimental conditions.

  1995cited by this paper
• Swallowing and esophageal function in Parkinson's disease.

  1995cited by this paper
• Autonomic disorders in Parkinson's disease.

  1995cited by this paper
• Adynamic bowel syndrome in Parkinson's disease with dramatic response to apomorphine

  1994cited by this paper
• Characterization of swallowing and defecation in Parkinson's disease.

  1994cited by this paper
• Gastrointestinal dysfunction in Parkinson's disease

  1992cited by this paper
• Clonidine treatment of clozapine-induced hypersalivation.

  1992cited by this paper
• Saliva: its secretion, composition and functions

  1992cited by this paper
• Influence of Parkinson's disease on oral health.

  1992cited by this paper
• Castillo‐Morales' Orofacial Therapy: Treatment of 67 Children with Down Syndrome

  1991cited by this paper
• Gastrointestinal symptoms in Parkinson's disease

  1991cited by this paper
• Submandibular Gland Resection and Bilateral Parotid Duct Ligation as a Management for Chronic Drooling in Cerebral Palsy

  1989cited by this paper
• Physiology of swallowing.

  1989cited by this paper
• EFFICACY OF BENZTROPINE THERAPY FOR DROOLING

  1989cited by this paper
• Parkinsonism and aging

  1989cited by this paper
• Three treatment approaches and clinical factors in the reduction of drooling

  1988cited by this paper
• Longitudinal Age-related Changes in Human Parotid Saliva Composition

  1987cited by this paper
• Transtympanic neurectomies for control of drooling.

  1984cited by this paper
• Effects of Meditation

  1982cited by this paper
• Treatment of hyperkinetic movement disorders with tetrabenazine: A double‐blind crossover study

  1982cited by this paper
• Sialorrhea as a side effect of lithium: a case report.

  1982cited by this paper
• The role of the caudate-putamen nucleus in salivary secretion induced by L-DOPA.

  1982cited by this paper
• Long‐Term Follow‐Up of Tympanic Neurectomy for Sialorrhea

  1979cited by this paper
• Long-term follow-up of tympanic neurectomy for sialorrhea.

  1979cited by this paper
• Salivation: a review and experimental investigation of major techniques.

  1977cited by this paper

• Predictors of drooling severity in people with Parkinson’s disease

  2025cites this paper
• Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease

  2023cites this paper
• Presentations of nonmotor symptoms by sex and onset age in people with Parkinson's disease.

  2023cites this paper
• Salivary Complaints in Burning Mouth Syndrome: A Cross Sectional Study on 500 Patients

  2023cites this paper
• Sialorrhea in patients with Parkinson's disease: A case report

  2022cites this paper
• Drooling, Swallowing Difficulties and Health Related Quality of Life in Parkinson’s Disease Patients

  2021cites this paper
• Clinical features associated with drooling in Parkinson’s disease

  2021cites this paper
• Relationships of drooling with motor symptoms and dopamine transporter imaging in drug-naïve Parkinson's disease.

  2020cites this paper
• State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson’s disease

  2020cites this paper
• Sialorroe/overmatige speekselafscheiding

  2020cites this paper
• The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®)

  2019cites this paper
• Incobotulinumtoxin A for Sialorrhea in Neurological Disorders: A Real-Life Experience

  2018cites this paper
• [Salivation after stroke].

  2017cites this paper
• Quality of Life and Caregivers' Burden of Parkinson's Disease

  2017cites this paper
• Swallowing difficulties and Parkinson's disease

  2016cites this paper
• Design and development of a novel supportive care product for the treatment of sialorrhea in Parkinson's disease.

  2015cites this paper
• Diseases of the neurological system

  2015cites this paper
• Prevalence and clinical correlates of drooling in Parkinson disease: a study on 518 Chinese patients.

  2015cites this paper
• Diurnal drooling in Chinese patients with Parkinson's disease.

  2015cites this paper
• [Hypersalivation in Parkinson's disease: causes and treatment options].

  2015cites this paper
• Parkinson-potilaiden syömisen ja nielemisen sensomotoriset valmiudet. Ryhmätutkimus.

  2014cites this paper
• Drooling in Parkinson's disease: a review.

  2014cites this paper
• Rascol , Olivier Emerging drugs for autonomic dysfunction in Parkinson ' s disease

  2013cites this paper
• Emerging drugs for autonomic dysfunction in Parkinson's disease

  2013influential citation
• Dysphagia and sialorrhea: the relationship to Parkinson's disease.

  2013cites this paper
• Evaluation of Atropine 1% Ophthalmic Solution Administered Sublingually for the Management of Terminal Respiratory Secretions

  2013cites this paper
• Management of dysphagia and drooling in patients with Parkinson’s disease

  2013cites this paper
• Gender-related differences in the burden of non-motor symptoms in Parkinson's disease Pablo Martinez-MartinCristian Falup PecurariuPer OdinJacobus J. van Hilten • Angelo AntoniniJose M. Rojo-AbuinVanderci BorgesClaudia Trenkwalder • Dag AarslandDavid J. BrooksKallol Ray Chaudhuri

  2012cites this paper
• Impact of Progression of Parkinson’s Disease on Drooling in Various Ethnic Groups

  2012cites this paper
• Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease

  2012cites this paper
• Nonmotor Manifestations in Parkinson Disease

  2012cites this paper
• Gastrointestinal and Swallowing Disturbances in Parkinson's Disease

  2011cites this paper
• A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients.

  2011cites this paper
• Gastrointestinal dysfunction in Parkinson's disease.

  2011cites this paper
• Pathophysiology of diurnal drooling in Parkinson's disease

  2011cites this paper
• Clinical-therapeutic management of drooling: Review and update.

  2011cites this paper
• Parkinson's disease symptoms: The patient's perspective

  2010cites this paper
• Use of botulinum toxin in the neurology clinic

  2010cites this paper
• Glycopyrrolate for sialorrhea in Parkinson disease

  2010cites this paper
• Schluckstörungen und Therapiemöglichkeiten bei typischen und atypischen Parkinson-Syndromen

  2009cites this paper
• Sialorrhea and Salivary Composition in Patients With Parkinson ' s Disease

  2009cites this paper
• Hypersalivation in Parkinson ’ s disease : causes and treatment options

  year unknowncites this paper